Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment and Differentiation Factors of Keloid Scarring
NCT01295099Phase 4Withdrawn
- Sponsor
- Queen Mary University of London
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorouracil in keloid, sponsored by Queen Mary University of London. Status: withdrawn.
02
Drugs
fluorouracil
03
Conditions
keloid
Beyond the preview
Go deeper on NCT01295099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01295099.